Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2001 1
2005 2
2006 2
2007 2
2008 2
2010 1
2011 7
2012 19
2013 17
2014 23
2015 19
2016 14
2017 13
2018 10
2019 4
2020 6
2021 7
2022 7
2023 10
2024 11
2025 23

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

171 results

Results by year

Filters applied: . Clear all
Page 1
Interim 2024/25 influenza vaccine effectiveness: eight European studies, September 2024 to January 2025.
Rose AM, Lucaccioni H, Marsh K, Kirsebom F, Whitaker H, Emborg HD, Bolt Botnen A, O'Doherty MG, Pozo F, Hameed SS, Andrews N, Hamilton M, Trebbien R, Lauenborg Møller K, Marques DF, Murphy S, McQueenie R, Lopez-Bernal J, Cottrell S, Bucholc M, Kissling E; European IVE group; Members of the European IVE group. Rose AM, et al. Euro Surveill. 2025 Feb;30(7):2500102. doi: 10.2807/1560-7917.ES.2025.30.7.2500102. Euro Surveill. 2025. PMID: 39980423 Free PMC article.
Effectiveness of catch-up and at-birth nirsevimab immunisation against RSV hospital admission in the first year of life: a population-based case-control study, Spain, 2023/24 season.
Núñez O, Olmedo C, Moreno-Perez D, Lorusso N, Fernández Martínez S, Pastor Villalba PE, Gutierrez Á, Alonso Garcia M, Latasa P, Sancho R, Mendioroz J, Martinez-Marcos M, Muñoz Platón E, García Rivera MV, Pérez-Martinez O, Álvarez-Gil R, Rivas Wagner E, López Gonzalez-Coviella N, Zornoza M, Barranco MI, Pacheco MDC, Álvarez Río V, Fiol Jaume M, Morey Arance R, Adiego Sancho B, Mendez Diaz M, Batalla N, Andreu C, Castilla J, García Cenoz M, Fernández Ibáñez A, Huerta Huerta M, Ibáñez Pérez AC, Berradre Sáenz B, Lamas J, Hermoso L, Casado Cobo S, Galán Cuesta M, Montenegro S, Domínguez M, Jarrín I, Limia A, Pastor-Barriuso R, Monge S; Nirsevimab Effectiveness Study Collaborators. Núñez O, et al. Among authors: monge s. Euro Surveill. 2025 Feb;30(5):2400596. doi: 10.2807/1560-7917.ES.2025.30.5.2400596. Euro Surveill. 2025. PMID: 39916606 Free PMC article.
Severity of respiratory syncytial virus compared with SARS-CoV-2 and influenza among hospitalised adults ≥65 years.
Vega-Piris L, Carretero SG, Mayordomo JL, Zarzuelo MBR, Río VÁ, García VG, Vázquez MG, Rodríguez MDCG, Basile L, González-Coviella NL, Boada MIB, Pérez-Martínez O, Azevedo AL, Rubio CQ, Duran JG, Ibáñez AF, Rivera MVG, Marín VR, Castrillejo D, Raymundo LJV, Larrauri A, Monge S; SARI Sentinel Surveillance Group. Vega-Piris L, et al. Among authors: monge s. J Infect. 2024 Nov;89(5):106292. doi: 10.1016/j.jinf.2024.106292. Epub 2024 Sep 26. J Infect. 2024. PMID: 39341402 Free article.
Phlebovirus-associated diseases transmitted by phlebotominae in Spain: Are we at risk?
García San Miguel L, Sierra MJ, Vazquez A, Fernandez-Martínez B, Molina R, Sanchez-Seco MP, Lucientes J, Figuerola J, de Ory F, Monge S, Suarez B, Simón F. García San Miguel L, et al. Among authors: monge s. Enferm Infecc Microbiol Clin (Engl Ed). 2021 Aug-Sep;39(7):345-351. doi: 10.1016/j.eimce.2021.05.001. Epub 2021 May 16. Enferm Infecc Microbiol Clin (Engl Ed). 2021. PMID: 34353512 Review.
Monovalent XBB.1.5 COVID-19 vaccine effectiveness against hospitalisations and deaths during the Omicron BA.2.86/JN.1 period among older adults in seven European countries: A VEBIS-EHR network study.
Nunes B, Humphreys J, Nicolay N, Braeye T, Van Evercooren I, Holm Hansen C, Moustsen-Helms IR, Sacco C, Fabiani M, Castilla J, Martínez-Baz I, Meijerink H, Machado A, Soares P, Ljung R, Pihlström N, Nardone A, Bacci S, Monge S; VEBIS-EHR working group. Nunes B, et al. Among authors: monge s. Expert Rev Vaccines. 2024 Jan-Dec;23(1):1085-1090. doi: 10.1080/14760584.2024.2428800. Epub 2024 Nov 25. Expert Rev Vaccines. 2024. PMID: 39535047 Free article.
COVID-19 Vaccine Effectiveness Against Medically Attended Symptomatic SARS-CoV-2 Infection Among Target Groups in Europe, October 2024-January 2025, VEBIS Primary Care Network.
Laniece Delaunay C, Verdasca N, Monge S, Domegan L, Sève N, Buda S, Meijer A, Lucaccioni H, López Torrijos M, McKenna A, Enouf V, Dürrwald R, In't Velt E, de Valcárcel Laiglesia MÁ, Bennett C, Masse S, Erdwiens A, Hooiveld M, Mlinarić I, Túri G, Rodrigues AP, Martínez-Baz I, Lazar M, Latorre-Margalef N, Borges V, Kaczmarek M, Bacci S, Kissling E; European primary care VE group. Laniece Delaunay C, et al. Among authors: monge s. Influenza Other Respir Viruses. 2025 May;19(5):e70120. doi: 10.1111/irv.70120. Influenza Other Respir Viruses. 2025. PMID: 40395132 Free PMC article.
[Monitoring social determinants of health].
Espelt A, Continente X, Domingo-Salvany A, Domínguez-Berjón MF, Fernández-Villa T, Monge S, Ruiz-Cantero MT, Perez G, Borrell C; Grupo de Determinantes Sociales de la Salud de la Sociedad Española de Epidemiologia. Espelt A, et al. Among authors: monge s. Gac Sanit. 2016 Nov;30 Suppl 1:38-44. doi: 10.1016/j.gaceta.2016.05.011. Gac Sanit. 2016. PMID: 27837795 Free article. Spanish.
171 results